🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,027 results for “ERA” Clear

  1. Placebo

    Sarepta Therapeutics

    Ebola Hemorrhagic Fever

    phase 1 small molecule completed

    1 trial

  2. Placebo

    BioXcel Therapeutics

    Alcohol Use Disorder (AUD)

    phase 1 small molecule completed

    1 trial

  3. Placebo Intravaginal Ring A

    United Therapeutics Europe Ltd

    Safety

    phase 1 other terminated

    1 trial

  4. Placebo Vaginal Film with Square Corners

    United Therapeutics Europe Ltd

    Safety

    phase 1 small molecule completed

    1 trial

  5. Placebo for antibiotic

    Seres Therapeutics

    Metastatic Melanoma

    phase 1 small molecule completed

    1 trial

  6. Plasmodium falciparum Malaria Protein 010 (FMP010)

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  7. Plerixafor

    United Therapeutics Europe Ltd

    Pancreatic Adenocarcinoma Metastatic

    phase 1 small molecule completed

    1 trial

  8. Pociredir oral capsule(s)

    Fulcrum Therapeutics

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial

  9. Pramipexole

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  10. Prednisone

    Vertex Pharmaceuticals (Australia) Pty.

    Drug Interactions

    phase 1 small molecule completed

    1 trial

  11. PrimeC 748 mg

    NeuroSense Therapeutics

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  12. PrimeC-ER 748 mg

    NeuroSense Therapeutics

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  13. Prospective feasibility pilot study evaluating the value of [68Ga]Ga-PENTIXAFOR PET-CT in patients with locally advanced or metastatic Small Cell Lung Cancer (SCLC) at diagnosis and disease progression (PASSIFLORE)

    CERO THERAPEUTICS HOLDINGS, INC.

    cell lung carcinoma

    phase 1 other active

    1 trial

  14. Protexia

    United Therapeutics Europe Ltd

    Intervention for Nerve Agent Exposure

    phase 1 mab completed

    1 trial

  15. Provision of extra (care coordination and management) services

    United Therapeutics Europe Ltd

    Hospitalization

    phase 1 other completed

    1 trial

  16. Provox Xtra HME

    ATOSSA THERAPEUTICS, INC.

    Total Laryngectomy

    phase 1 other completed

    1 trial

  17. Psilocybin

    United Therapeutics Europe Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule active

    1 trial

  18. Q-Griffithsin

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule completed

    1 trial

  19. Q-Griffithsin 3.0

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule active

    1 trial

  20. QR-504a

    ProQR Therapeutics N.V.

    Fuchs Endothelial Corneal Dystrophy

    phase 1 small molecule terminated

    1 trial

  21. RBL001/RBL002

    Atrium Therapeutics

    Melanoma

    phase 1 mab completed

    1 trial

  22. RE-021, sparsentan

    Travere Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  23. REGN2176-3

    Regeneron UK Limited

    Neovascular Wet Age-related Macular Degeneration (AMD)

    phase 1 small molecule completed

    1 trial

  24. REL-1017

    RELMADA THERAPEUTICS, INC.

    Neuropathic Pain

    phase 1 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources